Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
FranceStudy of Elafibranor for Adults with Primary Biliary Cholangitis
FranceStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
FranceStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
FranceStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
FranceStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
FranceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
FranceStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
FranceStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
FranceStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
